Difluprednate
Anti-inflammatory · Rx
RxAnti-inflammatorySteroid Pink cap
| Strength | 0.05% |
|---|---|
| Typical quantity | 5 mL bottle (brand, limited generic) |
| Cash cost / month | High · ~$100-350 |
| Drug class | Corticosteroid, difluorinated (emulsion) |
| Mechanism of action | Highly potent difluorinated prednisolone derivative in an emulsion; strong penetration, no shaking required. |
| Indication / reason for use | Post-operative ocular inflammation and pain; endogenous anterior uveitis. |
| Usual adult dosing | 1 drop 2-4×/day (uveitis: QID then taper; post-op: QID for 2 weeks, then taper). |
| Preservative | Sorbic acid 0.1% (BAK-free) |
| Contact lenses | Do not wear lenses during treatment. |
| Common / important adverse effects | Significant IOP elevation can occur quickly, monitor closely; cataract, delayed healing, infection potentiation. |
| Contraindications & cautions | Active epithelial herpes simplex keratitis, most viral/fungal/mycobacterial infections. |
| Pregnancy / lactation | Limited data. |
| Pregnancy category (older labels) | No letter category on the current label. From DailyMed labels, checked Nov 2026. |
| Trade names | Durezol |
| Practice notes | Potent, smaller total daily drop count than prednisolone; watch IOP even on short courses, particularly in children. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.